Compare Stocks: PHR, SDGR, GDRX, and TDOC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GDRX GoodRx	$3.45 -3.1%	$3.13	$1.77 ▼ $5.81	$1.18B	1.6	1.83 million shs	1.75 million shs
PHR Phreesia	$12.10 +0.8%	$10.78	$7.77 ▼ $32.76	$749.16M	0.85	839,050 shs	919,685 shs
SDGR Schrodinger	$19.71 +0.7%	$16.45	$10.94 ▼ $23.02	$1.46B	1.63	1.16 million shs	1.09 million shs
TDOC Teladoc Health	$6.41 -1.2%	$8.08	$4.40 ▼ $9.89	$1.16B	2.12	5.88 million shs	3.47 million shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GDRX GoodRx	0.00%	-7.51%	+20.21%	+30.19%	-21.05%
PHR Phreesia	0.00%	-1.43%	+23.26%	+35.88%	-56.35%
SDGR Schrodinger	0.00%	+12.05%	+30.27%	+48.20%	+1.81%
TDOC Teladoc Health	0.00%	-6.07%	-26.18%	-2.66%	-11.16%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GDRX GoodRx	$3.45 -3.1%	$3.13	$1.77 ▼ $5.81	$1.18B	1.6	1.83 million shs	1.75 million shs
PHR Phreesia	$12.10 +0.8%	$10.78	$7.77 ▼ $32.76	$749.16M	0.85	839,050 shs	919,685 shs
SDGR Schrodinger	$19.71 +0.7%	$16.45	$10.94 ▼ $23.02	$1.46B	1.63	1.16 million shs	1.09 million shs
TDOC Teladoc Health	$6.41 -1.2%	$8.08	$4.40 ▼ $9.89	$1.16B	2.12	5.88 million shs	3.47 million shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GDRX GoodRx	0.00%	-7.51%	+20.21%	+30.19%	-21.05%
PHR Phreesia	0.00%	-1.43%	+23.26%	+35.88%	-56.35%
SDGR Schrodinger	0.00%	+12.05%	+30.27%	+48.20%	+1.81%
TDOC Teladoc Health	0.00%	-6.07%	-26.18%	-2.66%	-11.16%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GDRX GoodRx	2.08	Hold	$4.23	22.53% Upside
PHR Phreesia	2.42	Hold	$16.65	37.58% Upside
SDGR Schrodinger	2.29	Hold	$20.50	4.01% Upside
TDOC Teladoc Health	2.25	Hold	$7.54	17.56% Upside

Current Analyst Ratings Breakdown

Latest PHR, SDGR, GDRX, and TDOC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/20/2026	GDRX GoodRx	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Underweight	$3.00 ➝ $4.00
8/19/2026	TDOC Teladoc Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/14/2026	SDGR Schrodinger	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$13.00 ➝ $19.00
8/14/2026	SDGR Schrodinger	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$13.00 ➝ $19.00
8/13/2026	GDRX GoodRx	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$2.50 ➝ $3.75
8/12/2026	SDGR Schrodinger	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/11/2026	GDRX GoodRx	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$4.00 ➝ $5.00
8/11/2026	GDRX GoodRx	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$4.00 ➝ $5.00
8/7/2026	GDRX GoodRx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
8/7/2026	GDRX GoodRx	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$4.00
8/7/2026	GDRX GoodRx	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$3.50 ➝ $5.00

(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GDRX GoodRx	$796.85M	1.48	$0.40 per share	8.62	$1.89 per share	1.83
PHR Phreesia	$480.59M	1.56	$0.75 per share	16.24	$5.59 per share	2.16
SDGR Schrodinger	$255.87M	5.69	N/A	N/A	$4.46 per share	4.42
TDOC Teladoc Health	$2.53B	0.46	$1.81 per share	3.55	$7.21 per share	0.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GDRX GoodRx	$30.44M	$0.04	86.27	17.25	1.72	2.07%	7.22%	2.53%	11/3/2026 (Estimated)
PHR Phreesia	$2.31M	$0.15	80.67	17.54	N/A	1.85%	5.13%	3.12%	9/2/2026 (Estimated)
SDGR Schrodinger	-$103.26M	-$0.74	N/A	N/A	N/A	-20.98%	-16.37%	-8.19%	11/4/2026 (Estimated)
TDOC Teladoc Health	-$200.32M	-$0.99	N/A	N/A	N/A	-7.13%	-12.15%	-5.83%	10/28/2026 (Estimated)

Latest PHR, SDGR, GDRX, and TDOC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/2/2026	Q2 2027	PHR Phreesia	$0.11	N/A	N/A	N/A	$129.07 million	N/A
8/5/2026	Q2 2026	GDRX GoodRx	$0.0797	$0.08	+$0.0003	$0.02	$193.23 million	$200.41 million
8/5/2026	Q2 2026	SDGR Schrodinger	-$0.4145	$0.08	+$0.4945	$0.08	$47.19 million	$58.89 million
7/29/2026	Q2 2026	TDOC Teladoc Health	-$0.2498	-$0.21	+$0.0398	-$0.21	$615.44 million	$606.93 million
5/27/2026	Q1 2027	PHR Phreesia	$0.02	$0.05	+$0.03	$0.05	$130.08 million	$130.94 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
GDRX GoodRx	N/A	N/A	N/A	N/A	N/A
PHR Phreesia	N/A	N/A	N/A	N/A	N/A
SDGR Schrodinger	N/A	N/A	N/A	N/A	N/A
TDOC Teladoc Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GDRX GoodRx	0.74	1.38	1.38
PHR Phreesia	0.41	1.76	1.76
SDGR Schrodinger	N/A	2.71	2.71
TDOC Teladoc Health	N/A	0.83	0.81

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GDRX GoodRx	63.77%
PHR Phreesia	92.10%
SDGR Schrodinger	79.05%
TDOC Teladoc Health	76.82%

Insider Ownership

Company	Insider Ownership
GDRX GoodRx	5.87%
PHR Phreesia	5.20%
SDGR Schrodinger	10.10%
TDOC Teladoc Health	0.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GDRX GoodRx	950	342.57 million	322.47 million	Optionable
PHR Phreesia	1,789	61.81 million	58.60 million	Optionable
SDGR Schrodinger	790	73.82 million	66.37 million	Optionable
TDOC Teladoc Health	5,600	181.68 million	180.41 million	Optionable

PHR, SDGR, GDRX, and TDOC Headlines

Recent News About These Companies

Zacks Research Predicts Reduced Earnings for Teladoc Health

August 23 at 1:13 AM | americanbankingnews.com

Analysts Offer Predictions for Teladoc Health Q3 Earnings

August 21 at 7:41 AM | marketbeat.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 20 at 10:00 AM | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Teladoc Health, Inc. – TDOC

August 18, 2026 | globenewswire.com

U.S. Mental Health Treatment Market Report 2026–2030: Evaluating $159 Billion Forecast, Digital App Adoption, and Strategies of Acadia Healthcare, UHS, Talkspace, and Elevance Health

August 17, 2026 | finance.yahoo.com

Monaco Asset Management SAM Takes $26.86 Million Position in Teladoc Health, Inc. $TDOC

August 17, 2026 | marketbeat.com

Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

August 17, 2026 | prnewswire.com

Teladoc Announces Upcoming Retirement of Longtime Board Director

August 13, 2026 | tipranks.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 13, 2026 | prnewswire.com

HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum

August 12, 2026 | finance.yahoo.com

Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity

August 12, 2026 | finance.yahoo.com

Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?

August 12, 2026 | finance.yahoo.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 11, 2026 | globenewswire.com

1 Internet Stock with Impressive Fundamentals and 2 We Question

August 9, 2026 | finance.yahoo.com

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

August 8, 2026 | fool.com

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

August 7, 2026 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 6, 2026 | prnewswire.com

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced - Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

August 6, 2026 | tmcnet.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (TDOC) and Karyopharm Therapeutics (KPTI)

August 6, 2026 | theglobeandmail.com

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

August 5, 2026 | businesswire.com

Teladoc Shares Plunged More Than 28% After Earnings. How to Play TDOC Here.

August 5, 2026 | barchart.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHR, SDGR, GDRX, and TDOC Company Descriptions

GoodRx NASDAQ:GDRX

$3.45 -0.11 (-3.09%)

As of 08/21/2026 04:00 PM Eastern

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Phreesia NYSE:PHR

$12.10 +0.10 (+0.83%)

As of 08/21/2026 03:58 PM Eastern

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

Schrodinger NASDAQ:SDGR

$19.71 +0.13 (+0.66%)

As of 08/21/2026 04:00 PM Eastern

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Teladoc Health NYSE:TDOC

$6.41 -0.08 (-1.23%)

As of 08/21/2026 03:58 PM Eastern

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PHR, SDGR, GDRX, and TDOC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PHR, SDGR, GDRX, and TDOC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PHR, SDGR, GDRX, and TDOC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHR, SDGR, GDRX, and TDOC Company Descriptions

GoodRx NASDAQ:GDRX

Phreesia NYSE:PHR

Schrodinger NASDAQ:SDGR

Teladoc Health NYSE:TDOC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PHR, SDGR, GDRX, and TDOC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PHR, SDGR, GDRX, and TDOC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PHR, SDGR, GDRX, and TDOC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHR, SDGR, GDRX, and TDOC Company Descriptions

GoodRx NASDAQ:GDRX

Phreesia NYSE:PHR

Schrodinger NASDAQ:SDGR

Teladoc Health NYSE:TDOC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools